Consistently, the curative effect of EGCG on liver fibrosis was reversed by leupeptin and si-ATG5 treatment, as evidenced by the increased protein expression level of fibrosis-related gene α-SMA (Figure 6E) and increased collagen deposition (Figure 6F) in the liver tissues of rcccDNA mice. Here, ATG5 is linked to Hepatic fibrosis.